231 related articles for article (PubMed ID: 16997145)
21. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.
Ndounga M; Tahar R; Basco LK; Casimiro PN; Malonga DA; Ntoumi F
Trop Med Int Health; 2007 Oct; 12(10):1164-71. PubMed ID: 17956498
[TBL] [Abstract][Full Text] [Related]
22. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
[TBL] [Abstract][Full Text] [Related]
23. Mutational 'hot-spots' in mammalian, bacterial and protozoal dihydrofolate reductases associated with antifolate resistance: sequence and structural comparison.
Volpato JP; Pelletier JN
Drug Resist Updat; 2009; 12(1-2):28-41. PubMed ID: 19272832
[TBL] [Abstract][Full Text] [Related]
24. Antifolate screening using yeast expressing Plasmodium vivax dihydrofolate reductase and in vitro drug susceptibility assay for Plasmodium falciparum.
Djapa LY; Basco LK; Zelikson R; Rosowsky A; Djaman JA; Yonkeu JN; Bolotin-Fukuhara M; Mazabraud A
Mol Biochem Parasitol; 2007 Nov; 156(1):89-92. PubMed ID: 17727978
[TBL] [Abstract][Full Text] [Related]
25. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
O'Neil MT; Korsinczky ML; Gresty KJ; Auliff A; Cheng Q
J Infect Dis; 2007 Aug; 196(3):467-74. PubMed ID: 17597462
[TBL] [Abstract][Full Text] [Related]
26. In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum.
Ommeh S; Nduati E; Mberu E; Kokwaro G; Marsh K; Rosowsky A; Nzila A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3711-4. PubMed ID: 15388424
[TBL] [Abstract][Full Text] [Related]
27. Folate-synthesizing enzyme system as target for development of inhibitors and inhibitor combinations against Candida albicans-synthesis and biological activity of new 2,4-diaminopyrimidines and 4'-substituted 4-aminodiphenyl sulfones.
Otzen T; Wempe EG; Kunz B; Bartels R; Lehwark-Yvetot G; Hänsel W; Schaper KJ; Seydel JK
J Med Chem; 2004 Jan; 47(1):240-53. PubMed ID: 14695838
[TBL] [Abstract][Full Text] [Related]
28. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
Senkovich O; Schormann N; Chattopadhyay D
Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
[TBL] [Abstract][Full Text] [Related]
29. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
[TBL] [Abstract][Full Text] [Related]
30. Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.
Dasgupta T; Chitnumsub P; Kamchonwongpaisan S; Maneeruttanarungroj C; Nichols SE; Lyons TM; Tirado-Rives J; Jorgensen WL; Yuthavong Y; Anderson KS
ACS Chem Biol; 2009 Jan; 4(1):29-40. PubMed ID: 19146480
[TBL] [Abstract][Full Text] [Related]
31. Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi.
Nkhoma S; Molyneux M; Ward S
Acta Trop; 2007 May; 102(2):138-42. PubMed ID: 17544355
[TBL] [Abstract][Full Text] [Related]
32. Targeting DHFR in parasitic protozoa.
Anderson AC
Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
[TBL] [Abstract][Full Text] [Related]
33. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.
Auliff A; Wilson DW; Russell B; Gao Q; Chen N; Anh le N; Maguire J; Bell D; O'Neil MT; Cheng Q
Am J Trop Med Hyg; 2006 Oct; 75(4):617-21. PubMed ID: 17038682
[TBL] [Abstract][Full Text] [Related]
34. Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda.
Lynch C; Pearce R; Pota H; Cox J; Abeku TA; Rwakimari J; Naidoo I; Tibenderana J; Roper C
J Infect Dis; 2008 Jun; 197(11):1598-604. PubMed ID: 18471065
[TBL] [Abstract][Full Text] [Related]
35. Geographical distribution of amino acid mutations in Plasmodium vivax DHFR and DHPS from malaria endemic areas of Thailand.
Rungsihirunrat K; Sibley CH; Mungthin M; Na-Bangchang K
Am J Trop Med Hyg; 2008 Mar; 78(3):462-7. PubMed ID: 18337344
[TBL] [Abstract][Full Text] [Related]
36. Adaptation of a multi-drug resistant strain of Plasmodium falciparum from Peru to Aotus lemurinus griseimembra, A. nancymaae, and A. vociferans monkeys.
Collins WE; Sullivan JS; Hall P; Ruebush TK; Williams A; Grady KK; Bounngaseng A; Nace D; Williams T; Huber C; Galland GG; Barnwell JW; Sullivan JJ
Am J Trop Med Hyg; 2007 Aug; 77(2):261-5. PubMed ID: 17690397
[TBL] [Abstract][Full Text] [Related]
37. Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae.
Brophy VH; Vasquez J; Nelson RG; Forney JR; Rosowsky A; Sibley CH
Antimicrob Agents Chemother; 2000 Apr; 44(4):1019-28. PubMed ID: 10722506
[TBL] [Abstract][Full Text] [Related]
38. A common feature-based 3D-pharmacophore model generation and virtual screening: identification of potential PfDHFR inhibitors.
Adane L; Bharatam PV; Sharma V
J Enzyme Inhib Med Chem; 2010 Oct; 25(5):635-45. PubMed ID: 19995305
[TBL] [Abstract][Full Text] [Related]
39. para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
Zheng J; Rubin EJ; Bifani P; Mathys V; Lim V; Au M; Jang J; Nam J; Dick T; Walker JR; Pethe K; Camacho LR
J Biol Chem; 2013 Aug; 288(32):23447-56. PubMed ID: 23779105
[TBL] [Abstract][Full Text] [Related]
40. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols.
Kao TT; Wang KC; Chang WN; Lin CY; Chen BH; Wu HL; Shi GY; Tsai JN; Fu TF
Drug Metab Dispos; 2008 Mar; 36(3):508-16. PubMed ID: 18056255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
